Home
Editorial
Services
Interview
Q&A
Chronicle Specials
Pharma Mart
ePharmail
Archives
Tenders & Project
Tenders & Enquiries
Pharma Projects
Corporate
Company Profiles
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
Join Pharma
|
Login
Home
>
Editorial
you can get e-magazine links on WhatsApp.
Click here
Editorial
SITTING ON A POWDER KEG?
,
November 12, 2025
A GOOD INITIATIVE BY DCGI
,
November 05, 2025
THE HEARTLESS COUNTERFEITERS
,
November 01, 2025
OVER TO THE NMC
,
October 20, 2025
TREAD CAUTIOUSLY ON REFURBISHED MEDICAL DEVICES
,
October 15, 2025
SHOW ZERO TOLERANCE ON QUALITY LAPSES
,
October 08, 2025
A REFORMIST ENDEAVOUR BY PCI
,
October 01, 2025
A GST RELIEF FOR PATIENTS
,
September 24, 2025
A BOLD STEP TO RESHAPE INNOVATION LANDSCAPE
,
September 16, 2025
A WELCOME INITIATIVE
,
September 10, 2025
END THIS UNETHICAL PRACTICE
,
August 30, 2025
BETTER LATE THAN CLOSURE
,
August 26, 2025
QUALITY SHOULD REIN SUPREME
,
August 19, 2025
TREAD CAUTIOUSLY ON INTEGRATED MEDICAL COURSE
,
August 13, 2025
THE UNACCEPTABLE DELAY
,
August 06, 2025
A BOOSTER SHOT FOR INDIAN PHARMA
,
July 31, 2025
GROWING ACCEPTANCE OF IP
,
July 23, 2025
NPC BILL NEED OF THE HOUR
,
July 16, 2025
END THIS UNETHICAL TRADE PRACTICE
,
July 09, 2025
STILL A TOOTHLESS TIGER
,
July 01, 2025
Results Found:
1331
1
2
3
4
5
Go to
Total Number of Pages:
67
Loading...
Copyright © 2024 Saffron Media Pvt. Ltd |
About us
|
Contact us
|
Advertise
|
Feedback
|
Helpdesk
|
Disclaimer
|
Sitemap
|
Archives
|
Terms & Conditions